Fidelity Investments
AST.WS

Fidelity Investments’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Fidelity Investments’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-168,703
Closed -$84K – 2707
2017
Q2 		$84K Hold
168,703
– – ﹤0.01% 2604
2017
Q1 		$73K Hold
168,703
– – ﹤0.01% 2635
2016
Q4 		$92K Sell
168,703
-14,288
-8% -$7.64K ﹤0.01% 2637
2016
Q3 		$93K Hold
182,991
– – ﹤0.01% 2638
2016
Q2 		$37K Buy
+182,991
New +$95.3K ﹤0.01% 2643

Fidelity Investments's AST.WS Position: Q3 2017 in Review

Fidelity Investments sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 168,703 shares — an estimated $84K sold.

Fidelity Investments first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $93K in Q3 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Fidelity Investments reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Fidelity Investments sold 168,703 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $84K.
  • Fidelity Investments first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Fidelity Investments's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $93K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Fidelity Investments's 13F filing for Q3 2017, filed 13 Nov 2017.